SG

Srinivasarao Gandi

Director Director DIN 09765709
DIN 09765709 First appointment Oct 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2022
Shareholding value Locked Premium profile

About Srinivasarao Gandi

Data last updated:

Srinivasarao Gandi has 3 years in corporate governance. Formerly with 1 company, such as Oxeymed Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09765709
Primary Designation Director
First Appointment 14 Oct 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director14 Oct 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oxeymed Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Srinivasarao Gandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasarao Gandi

Srinivasarao Gandi has 3 years in corporate governance. Formerly with 1 company, such as Oxeymed Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Srinivasarao Gandi is associated with 0 companies as a director.

Srinivasarao Gandi has expertise in General Business.

Srinivasarao Gandi has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available